Key facts
- MACQUARIE GROUP LTD filed SCHEDULE 13G/A for Travere Therapeutics Inc Common Shares (TVTX).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2024.
MACQUARIE GROUP LTD - 31 Dec 2024 SCHEDULE 13G/A Report for Travere Therapeutics Inc Common Shares (TVTX)
- Filing Manager
- MACQUARIE GROUP LTD
- Reporting Manager
- Macquarie Group Limited
- Symbol
- TVTX
- Shares outstanding
- 86,929,735 shares
- Disclosed Ownership
- 4,259,557 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Feb 2025, 07:44:44 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
MACQUARIE GROUP LTD disclosed 4.9% ownership in Travere Therapeutics Inc Common Shares (TVTX) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Feb 2025, 07:44.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Macquarie Group Limited | 4.9% | 4,259,557 | 0 | 0 | /s/ Philip Alexander | Associate Director | |
| Macquarie Management Holdings Inc | 4.9% | 4,259,557 | 4,259,557 | 0 | /s/ Marty Wolin | Chief Compliance Officer | |
| Macquarie Investment Management Business Trust | 4.9% | 4,259,557 | 4,259,557 | 0 | /s/ Marty Wolin | Chief Compliance Officer |
CIK / CUSIP context first